Similar articles for PMID: 36215572

Year	Number of Results
2006	1
2008	1
2009	1
2011	1
2012	3
2013	4
2014	5
2015	11
2016	15
2017	13
2018	13
2019	15
2020	12
2021	6
2022	8
2023	10
2024	1

1

¹⁸F-FDG PET/CT Prediction of Treatment Outcomes in Human Papillomavirus-Positive, Locally Advanced Oropharyngeal Cancer Patients Receiving Deintensified Therapy: Results from NRG-HN002.

Subramaniam RM, DeMora L, Yao M, Yom SS, Gillison M, Caudell JJ, Waldron J, Xia P, Chung CH, Truong MT, Echevarria M, Chan JW, Geiger JL, Mell L, Seaward S, Thorstad WL, Beitler JJ, Sultanem K, Blakaj D, Le QT. Subramaniam RM, et al. J Nucl Med. 2023 Mar;64(3):362-367. doi: 10.2967/jnumed.122.264424. Epub 2022 Sep 2. J Nucl Med. 2023. PMID: 36215572 Free PMC article. Clinical Trial.

2

Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab.

Rosenthal DI, Harari PM, Giralt J, Bell D, Raben D, Liu J, Schulten J, Ang KK, Bonner JA. Rosenthal DI, et al. J Clin Oncol. 2016 Apr 20;34(12):1300-8. doi: 10.1200/JCO.2015.62.5970. Epub 2015 Dec 28. J Clin Oncol. 2016. PMID: 26712222 Free PMC article.

3

CT and FDG-PET radiologic biomarkers in p16+ oropharyngeal squamous cell carcinoma patients treated with definitive chemoradiotherapy.

Rosen BS, Wilkie JR, Sun Y, Ibrahim M, Casper KA, Miller JE, Chotchutipan T, Stucken CL, Bradford C, Prince MEP, Rosko AJ, Malloy KM, McLean SA, Chinn SB, Shuman AG, Spector ME, Swiecicki PL, Worden FP, Shah JL, Schonewolf CA, Chapman CH, Eisbruch A, Mierzwa ML. Rosen BS, et al. Radiother Oncol. 2021 Feb;155:174-181. doi: 10.1016/j.radonc.2020.10.006. Epub 2020 Oct 16. Radiother Oncol. 2021. PMID: 33069764 Free PMC article.

4

Reduced-Dose Radiation Therapy for HPV-Associated Oropharyngeal Carcinoma (NRG Oncology HN002).

Yom SS, Torres-Saavedra P, Caudell JJ, Waldron JN, Gillison ML, Xia P, Truong MT, Kong C, Jordan R, Subramaniam RM, Yao M, Chung CH, Geiger JL, Chan JW, O'Sullivan B, Blakaj DM, Mell LK, Thorstad WL, Jones CU, Banerjee RN, Lominska C, Le QT. Yom SS, et al. J Clin Oncol. 2021 Mar 20;39(9):956-965. doi: 10.1200/JCO.20.03128. Epub 2021 Jan 28. J Clin Oncol. 2021. PMID: 33507809 Free PMC article. Clinical Trial.

5

Association of Fludeoxyglucose F 18-Labeled Positron Emission Tomography and Computed Tomography With the Detection of Oropharyngeal Cancer Recurrence.

Sivarajah S, Isaac A, Cooper T, Zhang H, Puttagunta L, Abele J, Biron V, Harris J, Seikaly H, O' Connell DA. Sivarajah S, et al. JAMA Otolaryngol Head Neck Surg. 2018 Nov 1;144(11):1037-1043. doi: 10.1001/jamaoto.2018.2143. JAMA Otolaryngol Head Neck Surg. 2018. PMID: 30242338 Free PMC article.

6

Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial.

Gillison ML, Trotti AM, Harris J, Eisbruch A, Harari PM, Adelstein DJ, Jordan RCK, Zhao W, Sturgis EM, Burtness B, Ridge JA, Ringash J, Galvin J, Yao M, Koyfman SA, Blakaj DM, Razaq MA, Colevas AD, Beitler JJ, Jones CU, Dunlap NE, Seaward SA, Spencer S, Galloway TJ, Phan J, Dignam JJ, Le QT. Gillison ML, et al. Lancet. 2019 Jan 5;393(10166):40-50. doi: 10.1016/S0140-6736(18)32779-X. Epub 2018 Nov 15. Lancet. 2019. PMID: 30449625 Free PMC article. Clinical Trial.

7

Pre-CCRT 18-fluorodeoxyglucose PET-CT improves survival in patients with advanced stages p16-negative oropharyngeal squamous cell carcinoma via accurate radiation treatment planning.

Chen TM, Chen WM, Chen M, Shia BC, Wu SY. Chen TM, et al. J Otolaryngol Head Neck Surg. 2023 Feb 13;52(1):14. doi: 10.1186/s40463-023-00623-y. J Otolaryngol Head Neck Surg. 2023. PMID: 36782296 Free PMC article. Clinical Trial.

8

Use of Diffusion-Weighted Imaging and ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography Combined With Computed Tomography in the Response Assessment for (Chemo)radiotherapy in Head and Neck Squamous Cell Carcinoma.

Noij DP, Martens RM, Koopman T, Hoekstra OS, Comans EFI, Zwezerijnen B, de Bree R, de Graaf P, Castelijns JA. Noij DP, et al. Clin Oncol (R Coll Radiol). 2018 Dec;30(12):780-792. doi: 10.1016/j.clon.2018.09.007. Epub 2018 Oct 11. Clin Oncol (R Coll Radiol). 2018. PMID: 30318343

9

3'-deoxy-3'-[¹⁸F]-fluorothymidine PET/CT in early determination of prognosis in patients with esophageal squamous cell cancer: comparison with [¹⁸F]-FDG PET/CT.

Chen H, Li Y, Wu H, Sun L, Lin Q, Zhao L, An H. Chen H, et al. Strahlenther Onkol. 2015 Feb;191(2):141-52. doi: 10.1007/s00066-014-0744-8. Epub 2014 Aug 28. Strahlenther Onkol. 2015. PMID: 25163419

10

Head and neck PET/CT: therapy response interpretation criteria (Hopkins Criteria)-interreader reliability, accuracy, and survival outcomes.

Marcus C, Ciarallo A, Tahari AK, Mena E, Koch W, Wahl RL, Kiess AP, Kang H, Subramaniam RM. Marcus C, et al. J Nucl Med. 2014 Sep;55(9):1411-6. doi: 10.2967/jnumed.113.136796. Epub 2014 Jun 19. J Nucl Med. 2014. PMID: 24947059 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year